Article History
First Online: 16 December 2022
Competing interests
: C.B.G. has received consulting fees from AbbVie, Abiomed, Alnylam Pharmaceuticals, Anthos, Bayer Corporation, Boehringer Ingelheim, Boston Scientific Corporation, Bristol Myers Squibb, Cardionomics, CeleCor Therapeutics, Janssen Pharmaceutical, Medtronic, Merck, Novo Nordisk, Novartis Pharmaceutical Company, PLX Pharma, Pfizer and Philips. C.B.G. also has salary funded by Duke University grants sponsored by Boehringer Ingelheim, the Food and Drug Administration, Novartis Pharmaceutical Company and Philips. C.B.G. has equity in Tenac.io. The other authors declare no competing interests.